Gene · 51455
Papers1,571
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,571
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Three Human POLH Germline Variants Defective in Complementing the UV- and Cisplatin-Sensitivity of POLH-Deficient Cells. | Int J Mol Sci | 2023 | 36982269 | PubTator, text mining | PubMed |
| DNA Repair and Therapeutic Strategies in Cancer Stem Cells. | Cancers (Basel) | 2023 | 36980782 | PubTator, text mining | PubMed |
| REV7 in Cancer Biology and Management. | Cancers (Basel) | 2023 | 36980607 | PubTator, text mining | PubMed |
| Imatinib blocks tyrosine phosphorylation of Smad4 and restores TGF-β growth-suppressive signaling in BCR-ABL1-positive leukemia. | Signal Transduct Target Ther | 2023 | 36959211 | PubTator, text mining | PubMed |
| Exome-wide assessment of isolated biliary atresia: A report from the National Birth Defects Prevention Study using child-parent trios and a case-control design to identify novel rare variants. | Am J Med Genet A | 2023 | 36942736 | PubTator, text mining | PubMed |
| DNA Alkylation Damage by Nitrosamines and Relevant DNA Repair Pathways. | Int J Mol Sci | 2023 | 36902118 | PubTator, text mining | PubMed |
| CRS: a circadian rhythm score model for predicting prognosis and treatment response in cancer patients. | J Transl Med | 2023 | 36895015 | PubTator, text mining | PubMed |
| Nucleophosmin Plays a Role in Repairing DNA Damage and Is a Target for Cancer Treatment. | Cancer Res | 2023 | 36877156 | PubTator, text mining | PubMed |
| SB202190 Predicts BRAF-Activating Mutations in Primary Colorectal Cancer Organoids via Erk1-2 Modulation. | Cells | 2023 | 36831331 | PubTator, text mining | PubMed |
| A novel DNA damage repair gene-related prognostic model for evaluating the prognosis and tumor microenvironment infiltration of esophageal squamous cell carcinoma. | BMC Med Genomics | 2023 | 36803971 | PubTator, text mining | PubMed |
| Advanced strategies for nucleic acids and small-molecular drugs in combined anticancer therapy. | Int J Biol Sci | 2023 | 36778126 | PubTator, text mining | PubMed |
| Mitotic DNA synthesis in response to replication stress requires the sequential action of DNA polymerases zeta and delta in human cells. | Nat Commun | 2023 | 36759509 | PubTator, text mining | PubMed |
| APE2: catalytic function and synthetic lethality draw attention as a cancer therapy target. | NAR Cancer | 2023 | 36755963 | PubTator, text mining | PubMed |
| Roles of trans-lesion synthesis (TLS) DNA polymerases in tumorigenesis and cancer therapy. | NAR Cancer | 2023 | 36755961 | PubTator, text mining | PubMed |
| Comprehensive structural characterization of the human AAA+ disaggregase CLPB in the apo- and substrate-bound states reveals a unique mode of action driven by oligomerization. | PLoS Biol | 2023 | 36745679 | PubTator, text mining | PubMed |
| Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity. | Nat Commun | 2023 | 36737435 | PubTator, text mining | PubMed |
| Proteomics and Metabolomics Analysis Reveals the Toxicity of ZnO Quantum Dots on Human SMMC-7721 Cells. | Int J Nanomedicine | 2023 | 36683595 | PubTator, text mining | PubMed |
| Mammalian life depends on two distinct pathways of DNA damage tolerance. | Proc Natl Acad Sci U S A | 2023 | 36669105 | PubTator, text mining | PubMed |
| A CRISPR screen in intestinal epithelial cells identifies novel factors for polarity and apical transport. | Elife | 2023 | 36661306 | PubTator, text mining | PubMed |
| Inactivation of Mad2B Enhances Apoptosis in Human Cervical Cancer Cell Line upon Cisplatin-Induced DNA Damage. | Biomol Ther (Seoul) | 2023 | 36642928 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51455/papers?page=8